The national prevalence of current depression, lifetime diagnosis of depression, and lifetime diagnosis of anxiety is 8.7 %, 15.7 %, and 11.3 %, respectively. There is considerable variability within and across states for all three measures. The most striking within-state difference in current depression between MMSAs is in California: 5.4 % and 11.3 %.
Introduction
There are differences and similarities in the prevalence of depression and anxiety both between and within Westernized countries. The prevalence of having any World Mental Health Composite International Diagnostic Interview of the Diagnostic Statistical Manual 4 th edition (WMH-CIDI/DSM-IV) disorder in the prior year varied widely from 8.2 % in Italy to 26.4 % in the United States. 1 The 12-month prevalence of anxiety ranged from 5.8 % in Italy to 18.2 % in the United States and for mood disorders ranged from 3.6 % in Germany to 9.6 % in the United States. 1 According to Ayuso-Mateos et al. 2 , rural communities had a similar prevalence of depressive disorders across different countries whereas urban areas varied markedly across countries. Rates of depressive disorders in Liverpool, UK were more than six times higher, and in Oslo, Norway over three times higher, than those in Santander, Spain 2 . In Europe, some rural communities show a lower prevalence of depressive disorders than urban ones. 2, 3 In Britain and Ireland urban rates of depressive disorders were two to three times higher than in their rural communities 3, 4 , but in Finland and Norway there were little differences between urban and rural rates of depressive disorders. 2 However, in the United States, there was a slight but significantly higher prevalence of depression in rural areas than urban areas. 5 Given this variability, we sought to examine the prevalence of current depression, a lifetime diagnosis of depression, and a lifetime diagnosis of anxiety at the state and metropolitan and micropolitan statistical area (MMSA) level in the U.S. population.
Methods

Behavioral Risk Factor Surveillance System
The Behavioral Risk Factor Surveillance System (BRFSS) is a state-based cross-sectional telephone survey operated by state health departments with assistance from the Centers for Dis- 
Anxiety and Depression Module
We used the standardized and validated PHQ-8 to examine depression by MMSA. 9 The PHQ-8 consists of eight of the nine criteria by which depressive disorders are diagnosed according to the DSM-IV. 10 The PHQ-8 is half the length of many other depression measures and has comparable sensitivity and specificity. 9 The ninth DSM-IV criterion was omitted because it assesses suicidal or self-injurious ideation, for which adequate intervention could not be conducted over the telephone. Research indicates that deletion of this question has only a minor effect on scoring because thoughts of selfharm are fairly uncommon in the general population. 9 The PHQ has been used in both clinical settings [11] [12] [13] and population-based settings 14 and in both self-administered [11] [12] [13] and telephone-administered modes. 15 Additionally, it has proven effective for detecting depressive symptoms in various racial/ ethnic groups. 13, 16 The response set was standardized to be similar to other BRF-SS questions by asking the number of days in the past 2 weeks that the person experienced a particular depressive symptom. The modified response set was converted back to the original PHQ-8 response set: 0 to 1 days = "not at all"; 2 to 6 days = "several days"; 7 to 11 days = "more than half the days"; and 12 to 14 days = "nearly every day"; points 0 to 3 were assigned to each category, respectively. Item scores are added for a total score ranging from 0 to 24. A total score of 0 to 4 represents no significant depressive symptoms, a total score of 5 to 9 represents mild depressive symptoms, 10 to 14 represents moderate depression, 15 to 19 represents moderately severe depression, and 20 to 24 represents severe depression. 9 Current depression was defined as a PHQ-8 score of 10 or higher, which has approximately 88 % sensitivity and specificity for major depression. 17 The remaining two questions of the module assessed depression and anxiety disorders diagnosed by a health care professional. Figure 1) . Among the MMSAs, the prevalence of current depression ranged from 4.3 % (95 % CI, 3.1-6.1) in the Des Moines, Iowa MMSA to 13.7 % (95 % CI, 10.6-17.4) in the Charleston, West Virginia MMSA (median, 7.8 %). There were also significant differences between the state estimates and the MMSAs within the state; 21 states out of 31 states with MMSA data. For example, 8.8 % of the Jacksonville, Mississippi MMSA had current depression while the prevalence for Mississippi was 13.0 % (Z = 7.0). Among the 23 states that had at least 2 MMSAs, there were five MMSA high-low combinations that were significantly different from each other. The most striking difference between MMSAs in a given 
Results
Current depression
Discussion
To our knowledge, this is the first study to examine the prevalence of anxiety and depression at the MMSA level in the 19 However, the majority of patients who screen positive who do not have major depression will still have clinically significant depressive symptoms or disorders, including dysthymic disorder and subsyndromal depression with functional impairment. 20 Moreover, analysis of BRFSS data has shown that most individuals with a PHQ-8 score of 10 or greater have either a DSM-IV depressive disorder or functionally impairing depressive symptoms when using a DSM-IV diagnostic algorithm as the criterion standard. 21 Despite these limitations, this research strongly suggests that mental illness prevention and intervention strategies be targeted at the local level in the United States.
